Qualitative and quantitative status of cytochrome P450s after the administration of a liposomal platelet substitute in rat liver

Reference

• Food and Drug Administration: Clinical Drug Interaction Studies - Study Design, Data Analysis, and Clinical Implications Guidance for Industry DRAFT GUIDANCE. [accessed 2020 Aug 15]. https://www.regulations.gov/document?D=FDA-2017-D-5961-0002
   Google Scholar
• Hagisawa K, Kinoshita M, Takikawa M, Takeoka S, Saitoh D, Seki S, Sakai H. 2019. Combination therapy using fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits. Transfusion 59(10):3186–3196. doi: 10.1111/trf.15427.
   Google Scholar
• Hashimoto M, Taguchi K, Ogaki S, Watanabe H, Kinoshita M, Nishikawa K, Takeoka S, Ikeda Y, Handa M, Otagiri M, Maruyama T. 2015. Pharmacokinetic Properties of Single and Repeated Injection of Liposomal Platelet Substitute in a Rat Model of Red Blood Cell Transfusion-Induced Dilutional Thrombocytopenia. J Pharm Sci. 104(11):3968–3976. doi: 10.1002/jps.24607.
   Google Scholar
• Ishiguro A, Sato R, Nagai N. 2020. Development of a new Japanese guideline on drug interaction for drug development and appropriate provision of information. Drug Metab Pharmacokinet. 35(1):12–17. doi: 10.1016/j.dmpk.2019.11.009.
   Google Scholar
• Kaneko K, Hagisawa K, Kinoshita M, Ohtsuka Y, Sasa R, Hotta M, Saitoh D, Sato K, Takeoka S, Terui K. 2023. Early treatment with Fibrinogen γ-chain peptide-coated, ADP-encapsulated Liposomes (H12-(ADP)-liposomes) ameliorates post-partum hemorrhage with coagulopathy caused by amniotic fluid embolism in rabbits. AJOG global reports. 3(4): 100280. doi: 10.1016/J.XAGR.2023.100280.
   Google Scholar
• Ogaki S, Taguchi K, Maeda H, Watanabe H, Ishima Y, Otagiri M, Maruyama T. 2015. Kupffer cell inactivation by carbon monoxide bound to red blood cells preserves hepatic cytochrome P450 via anti-oxidant and anti-inflammatory effects exerted through the HMGB1/TLR-4 pathway during resuscitation from hemorrhagic shock. Biochem Pharmacol. 97(3):310–319. doi: 10.1016/j.bcp.2015.07.035.
   Google Scholar
• Okamura Y, Katsuno S, Suzuki H, Maruyama H, Handa M, Ikeda Y, Takeoka S. 2010. Release abilities of adenosine diphosphate from phospholipid vesicles with different membrane properties and their hemostatic effects as a platelet substitute. Journal of Controlled Release. 148(3):373–379. doi: 10.1016/j.jconrel.2010.09.013.
   Google Scholar
• Okamura Y, Takeoka S, Eto K, Maekawa I, Fujie T, Maruyama H, Ikeda Y, Handa M. 2009. Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute. J Thromb Haemost. 7(3):470–7. doi: 10.1111/j.1538-7836.2008.03269.x.
   Google Scholar
• Saravanakumar A, Sadighi A, Ryu R, Akhlaghi F. 2019. Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016. Clin Pharmacokinet. 58(10):1281–1294. doi: 10.1007/s40262-019-00750-8.
   Google Scholar
• Taguchi K, Hashimoto M, Ogaki S, Watanabe H, Takeoka S, Ikeda Y, Handa M, Otagiri M, Maruyama T. 2015. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model. J Pharm Sci. 104(9):3084–3091. doi: 10.1002/jps.24418.
   Google Scholar
• Taguchi K., Ujihira H, Ogaki S, Watanabe H, Fujiyama A, Doi M, Okamura Y, Takeoka S, Ikeda Y, Handa M, et al. 2013. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute. Drug Metabolism and Disposition. 41(8):1584–1591. doi: 10.1124/dmd.112.050005.
   Google Scholar
• Taguchi K, Ujihira H, Watanabe H, Fujiyama A, Doi M, Takeoka S, Ikeda Y, Handa M, Otagiri M, Maruyama T. 2013. Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model. J Pharm Sci. 102(10):3852–3859. doi: 10.1002/JPS.23692.
   Google Scholar
• Tokuno M, Taguchi K, Sakai H, Ohtsuki S, Yamasaki K, Otagiri M. 2020a. Evaluation of cytochrome P450-based drug metabolism in hemorrhagic shock rats that were transfused with native and an artificial red blood cell preparation, Hemoglobin-vesicles. Drug Metab Pharmacokinet. 35(5):417–424. doi: 10.1016/j.dmpk.2020.06.004.
   Google Scholar
• Tokuno M, Taguchi K, Sakai H, Ohtsuki S, Yamasaki K, Otagiri M. 2020b. Assessing cytochrome P450-based drug-drug interactions with Hemoglobin-vesicles, an artificial red blood cell preparation, in healthy rats. Drug Metab Pharmacokinet. 35(5):425–431. doi: 10.1016/j.dmpk.2020.06.005.
   Google Scholar
• Tokuno M, Taguchi K, Yamasaki K, Otagiri M. 2020. Hepatic Cytochrome P450 Profiles in Hemorrhagic Shock Model Rats After Transfusion With Stored Red Blood Cells. J Pharm Sci. 109(11):3490–3495. doi: 10.1016/J.XPHS.2020.08.015.
   Google Scholar
• Wang F, Wu Y, Zhang J, Wang H, Xie X, Ye X, Peng D, Chen W. 2019. Induction of cytochrome P450 involved in the accelerated blood clearance phenomenon induced by pegylated liposomes in vivo. Drug Metabolism and Disposition. 47(4):364–376. doi: 10.1124/dmd.118.085340.
   Google Scholar